Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype

Author： Ilveskoski E.   Lehtimäki T.   Laaksonen R.   Janatuinen T.   Vesalainen R.   Nuutila P.   Laippala P.   Karhunen P. J.   Knuuti J.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.67, Iss.7, 2007-01, pp. : 723-734

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid Lowering Therapy with Fluvastatin and Pravastatin in Patients with HIV Infection and Antiretroviral Therapy: Comparison of Efficacy and Interaction with Indinavir

By Benesic A.  

Infection, Vol. 32, Iss. 4, 2004-08 ,pp. : 229-233

Springer Publishing Company

Access to resources Recommend Favorite

Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?

By Krishnamoorthy Suresh   Lip Gregory YH  

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 487-489

Future Medicine

Access to resources Recommend Favorite

Pioglitazone boosts conventional lipid-lowering therapy for familial combined hyperlipidemia

By  

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 259-261

Future Medicine

Access to resources Recommend Favorite

Meta-Analysis of Lipid-Lowering Therapy in Maintenance Dialysis Patients

By  

Nephron Clin Pract, Vol. 124, Iss. 3-4, 2014-01 ,pp. : 209-217

Karger

Access to resources Recommend Favorite

Seasonal Variation of Lipid-Lowering Effects of Complex Spa Therapy

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 10, Iss. 2, 2003-05 ,pp. : 78-84

Karger

Access to resources Recommend Favorite